In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line

PURPOSE: Human papillomavirus (HPV) type 16 is one of the major etiologic factors of cervical cancer. Our study aims to investigate the potentiality of the antiviral clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system (CRISPR/Cas9) targeting the E6 and E7...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhen, Shuai, Lu, Jiao-Jiao, Wang, Li-Jie, Sun, Xiao-Min, Zhang, Jia-Qi, Li, Xu, Luo, Wen-Juan, Zhao, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094426/
https://www.ncbi.nlm.nih.gov/pubmed/27816686
http://dx.doi.org/10.1016/j.tranon.2016.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094426/
https://www.ncbi.nlm.nih.gov/pubmed/27816686
http://dx.doi.org/10.1016/j.tranon.2016.10.002

Ejemplares similares